Nov 28 (Reuters) - Exopharm Ltd (EX1) :
- IAN DIXON EMPLOYMENT AS CEO IS EXPECTED TO END IN EARLY CY 24.
- IS MINIMISING NON- ESSENTIAL COSTS
- WORKING TO BRING POTENTIAL TRANSACTION TO SHAREHOLDERS AND HAVE COMPANY'S SHARES RECOMMENCE TRADING
- DETERMINED THAT A FULL-TIME CEO ROLE WILL NOT BE REQUIRED GOING FORWARD
- SEEKING A TRANSACTION THAT COULD RESULT IN A MATERIAL CHANGE IN COMPANY'S ACTIVITIES
Nov 28 (Reuters) - Exopharm Ltd (EX1) : IAN DIXON EMPLOYMENT AS...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
-0.001(4.76%) |
Mkt cap ! $21.78M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 2.0¢ | $26.45K | 1.321M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 356086 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 409325 | 2 |
View Market Depth
| Last trade - 13.51pm 14/08/2024 (20 minute delay) ? |
| TYP (ASX) Chart |